Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
12/01/2022 | Akouos, Inc. | AKUS | Disposition | Stock Option (right to buy) | 16k | $4.21 | $67.4k | | 11/30/2022 |
11/30/2022 | Akouos, Inc. | AKUS | Other | Common Stock | 5.9k | $0.00 | $0 | | 11/30/2022 |
06/23/2022 | Akouos, Inc. | AKUS | Grant | Stock Option (right to buy) | 16k | $4.21 | $67.4k | | 06/23/2022 |
06/14/2022 | Fusion Pharmaceuticals Inc. | FUSN | Grant | Stock Option (Right to Buy) | 17k | $3.60 | $61.2k | | 06/14/2022 |
06/24/2021 | Karuna Therapeutics, Inc. | KRTX | Other (acquisition) | Common Stock | 184 | $0.00 | $0 | | 06/24/2021 |
06/24/2021 | Akouos, Inc. | AKUS | Grant | Stock Option (right to buy) | 16k | $13.39 | $214.2k | | 06/24/2021 |
06/16/2021 | Karuna Therapeutics, Inc. | KRTX | Grant | Option (right to buy) | 8.5k | $128.01 | $1.1M | | 06/16/2021 |
06/04/2021 | Fusion Pharmaceuticals Inc. | FUSN | Grant | Stock Option (Right to Buy) | 17k | $8.15 | $138.6k | | 06/04/2021 |
03/08/2021 | Karuna Therapeutics, Inc. | KRTX | Other (acquisition) | Common Stock | 572 | $0.00 | $0 | | 03/08/2021 |
09/04/2020 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 350 | $72.36 | $25.3k | | 09/04/2020 |
06/30/2020 | Fusion Pharmaceuticals Inc. | FUSN | Purchase | Common Stock | 8.8k | $17.00 | $150k | | 06/30/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Conversion | Common Stock | 1.5M | $0.00 | $0 | See Footnote | 06/30/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Purchase | Common Stock | 294.1k | $17.00 | $5M | See Footnote | 06/30/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Purchase | Common Stock | 5.9k | $17.00 | $100k | | 06/30/2020 |
06/30/2020 | Akouos, Inc. | AKUS | Conversion | Series B Preferred Stock | 1.5M | $0.00 | $0 | See Footnote | 06/30/2020 |
06/25/2020 | Fusion Pharmaceuticals Inc. | FUSN | Grant | Stock Option (Right to Buy) | 30k | $17.00 | $510k | | 06/25/2020 |
06/04/2020 | Karuna Therapeutics, Inc. | KRTX | Grant | Option (right to buy) | 12.5k | $97.59 | $1.2M | | 06/04/2020 |
03/12/2020 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 550 | $69.17 | $38k | | 03/10/2020 |
03/12/2020 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 500 | $70.00 | $35k | | 03/10/2020 |
03/12/2020 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 500 | $73.00 | $36.5k | | 03/10/2020 |
03/12/2020 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 500 | $74.91 | $37.5k | | 03/10/2020 |
03/10/2020 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 1000 | $80.00 | $80k | | 03/10/2020 |
01/09/2020 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 788 | $70.50 | $55.6k | | 01/09/2020 |
01/03/2020 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 289 | $69.00 | $19.9k | | 01/03/2020 |
01/03/2020 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 1.1k | $70.00 | $79.7k | | 01/03/2020 |
12/31/2019 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 185 | $70.00 | $13k | | 12/31/2019 |
10/22/2019 | ALDER BIOPHARMACEUTICALS INC | ALDR | Disposition | Stock Option (Right to Buy) | 6.4k | $39.66 | $251.8k | | 10/22/2019 |
10/22/2019 | ALDER BIOPHARMACEUTICALS INC | ALDR | Disposition | Stock Option (Right to Buy) | 15k | $29.26 | $438.9k | | 10/22/2019 |
10/22/2019 | ALDER BIOPHARMACEUTICALS INC | ALDR | Disposition | Stock Option (Right to Buy) | 15k | $16.90 | $253.5k | | 10/22/2019 |
06/27/2019 | Karuna Therapeutics, Inc. | KRTX | Grant | Stock Option (Right to Buy) | 16.2k | $16.00 | $260k | | 06/27/2019 |
06/19/2019 | Entasis Therapeutics Holdings Inc. | ETTX | Grant | Stock Option (Right to Buy) | 7.5k | $6.12 | $45.9k | | 06/19/2019 |
06/11/2019 | OTONOMY, INC. | OTIC | Grant | Stock Option (right to buy) | 17.5k | $2.35 | $41.1k | | 06/11/2019 |
09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Common Stock | 359.3k | $0.00 | $0 | See Footnote | 09/28/2018 |
09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Common Stock | 458.4k | $0.00 | $0 | See Footnote | 09/28/2018 |
09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Purchase | Common Stock | 337.7k | $15.00 | $5.1M | See Footnote | 09/28/2018 |
|